Fresh Rounds

Medicenna Therapeutics Corp. funding

Medicenna Therapeutics Corp., a biotechnology company based in Toronto, Ontario, Canada, filed a Form D with the SEC on July 6, 2026 and reported $253K raised of a $2.3M offering.

Amount raised$253K
Offering size$2.3M
Filed with the SECJuly 6, 2026
First saleMay 28, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise, Other
LocationToronto, Ontario, Canada
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far3
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds